Monitoring the Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer Using Ultrasound Scattering Coefficient - A Preliminary Report

Dobruch-Sobczak K, Piotrzkowska-Wróblewska H, Klimoda Z, Secomski W, Karwat P and Litniewski J
Additional contact information
Dobruch-Sobczak K: Ultrasound Department, Institute of Fundamental Technological Research, Poland
Litniewski J: Ultrasound Department, Institute of Fundamental Technological Research, Poland

Biomedical Journal of Scientific & Technical Research, 2018, vol. 12, issue 3, 9283-9292

Abstract: Neoadjuvant chemotherapy (NAC) was initially used in locally advanced breast cancer (LABC) and the inflammatory form of cancer. Currently, it is recommended for patients with Stage 2 or 3, HER-2 positive or triple-negative (TNBC) breast cancer...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.002262.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.002262.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:12:y:2018:i:3:p:9283-9292

DOI: 10.26717/BJSTR.2018.12.002262

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().